Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities

Bullous pemphigoid (BP) is an autoimmune blistering disease mainly affecting elderly individuals. Comorbidities are common in patients with BP and have been found to complicate the management and prognosis. We describe a patient with multiple comorbidities who was successfully treated with omalizuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jue, Xiang, Tingkai, Wang, Wei, Bu, Zhangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314756/
https://www.ncbi.nlm.nih.gov/pubmed/35903519
http://dx.doi.org/10.2147/CCID.S373682
_version_ 1784754394056622080
author Liu, Jue
Xiang, Tingkai
Wang, Wei
Bu, Zhangyu
author_facet Liu, Jue
Xiang, Tingkai
Wang, Wei
Bu, Zhangyu
author_sort Liu, Jue
collection PubMed
description Bullous pemphigoid (BP) is an autoimmune blistering disease mainly affecting elderly individuals. Comorbidities are common in patients with BP and have been found to complicate the management and prognosis. We describe a patient with multiple comorbidities who was successfully treated with omalizumab and suggest omalizumab as a good alternative therapy for BP to prevent treatment-related complications in elderly patients with a poor general condition.
format Online
Article
Text
id pubmed-9314756
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93147562022-07-27 Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities Liu, Jue Xiang, Tingkai Wang, Wei Bu, Zhangyu Clin Cosmet Investig Dermatol Case Report Bullous pemphigoid (BP) is an autoimmune blistering disease mainly affecting elderly individuals. Comorbidities are common in patients with BP and have been found to complicate the management and prognosis. We describe a patient with multiple comorbidities who was successfully treated with omalizumab and suggest omalizumab as a good alternative therapy for BP to prevent treatment-related complications in elderly patients with a poor general condition. Dove 2022-07-21 /pmc/articles/PMC9314756/ /pubmed/35903519 http://dx.doi.org/10.2147/CCID.S373682 Text en © 2022 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Liu, Jue
Xiang, Tingkai
Wang, Wei
Bu, Zhangyu
Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title_full Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title_fullStr Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title_full_unstemmed Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title_short Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
title_sort case report: omalizumab successfully treated recalcitrant bullous pemphigoid in an elderly patient with multiple comorbidities
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314756/
https://www.ncbi.nlm.nih.gov/pubmed/35903519
http://dx.doi.org/10.2147/CCID.S373682
work_keys_str_mv AT liujue casereportomalizumabsuccessfullytreatedrecalcitrantbullouspemphigoidinanelderlypatientwithmultiplecomorbidities
AT xiangtingkai casereportomalizumabsuccessfullytreatedrecalcitrantbullouspemphigoidinanelderlypatientwithmultiplecomorbidities
AT wangwei casereportomalizumabsuccessfullytreatedrecalcitrantbullouspemphigoidinanelderlypatientwithmultiplecomorbidities
AT buzhangyu casereportomalizumabsuccessfullytreatedrecalcitrantbullouspemphigoidinanelderlypatientwithmultiplecomorbidities

Ejemplares similares